142 related articles for article (PubMed ID: 11347960)
1. Piperidine renin inhibitors: from leads to drug candidates.
Märki HP; Binggeli A; Bittner B; Bohner-Lang V; Breu V; Bur D; Coassolo PH; Clozel JP; D'Arcy A; Doebeli H; Fischli W; Funk CH; Foricher J; Giller T; Grüninger F; Guenzi A; Güller R; Hartung T; Hirth G; Jenny CH; Kansy M; Klinkhammer U; Lave T; Lohri B; Luft FC; Mervaala EM; Müller DN; Müller M; Montavon F; Oefner CH; Qiu C; Reichel A; Sanwald-Ducray P; Scalone M; Schleimer M; Schmid R; Stadler H; Treiber A; Valdenaire O; Vieira E; Waldmeier P; Wiegand-Chou R; Wilhelm M; Wostl W; Zell M; Zell R
Farmaco; 2001; 56(1-2):21-7. PubMed ID: 11347960
[TBL] [Abstract][Full Text] [Related]
2. Piperidine-renin inhibitors compounds with improved physicochemical properties.
Güller R; Binggeli A; Breu V; Bur D; Fischli W; Hirth G; Jenny C; Kansy M; Montavon F; Müller M; Oefner C; Stadler H; Vieira E; Wilhelm M; Wostl W; Märki HP
Bioorg Med Chem Lett; 1999 May; 9(10):1403-8. PubMed ID: 10360745
[TBL] [Abstract][Full Text] [Related]
3. Design and optimization of new piperidines as renin inhibitors.
Corminboeuf O; Bezençon O; Grisostomi C; Remeň L; Richard-Bildstein S; Bur D; Prade L; Hess P; Strickner P; Fischli W; Steiner B; Treiber A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6286-90. PubMed ID: 20843686
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
Mervaala E; Müller DN; Schmidt F; Park JK; Gross V; Bader M; Breu V; Ganten D; Haller H; Luft FC
Hypertension; 2000 Feb; 35(2):587-94. PubMed ID: 10679502
[TBL] [Abstract][Full Text] [Related]
5. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
[TBL] [Abstract][Full Text] [Related]
6. The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
Cody WL; Holsworth DD; Powell NA; Jalaie M; Zhang E; Wang W; Samas B; Bryant J; Ostroski R; Ryan MJ; Edmunds JJ
Bioorg Med Chem; 2005 Jan; 13(1):59-68. PubMed ID: 15582452
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
[TBL] [Abstract][Full Text] [Related]
8. Piperidine-based renin inhibitors: upper chain optimization.
Corminboeuf O; Bezençon O; Remeň L; Grisostomi C; Richard-Bildstein S; Bur D; Prade L; Strickner P; Hess P; Fischli W; Steiner B; Treiber A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6291-6. PubMed ID: 20843690
[TBL] [Abstract][Full Text] [Related]
9. Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?
Oefner C; Binggeli A; Breu V; Bur D; Clozel JP; D'Arcy A; Dorn A; Fischli W; Grüninger F; Güller R; Hirth G; Märki H; Mathews S; M ller M; Ridley RG; Stadler H; Vieira E; Wilhelm M; Winkler F; Wostl W
Chem Biol; 1999 Mar; 6(3):127-31. PubMed ID: 10074464
[TBL] [Abstract][Full Text] [Related]
10. Dose effects of human renin in rats transgenic for human angiotensinogen.
Bohlender J; Ménard J; Luft FC; Ganten D
Hypertension; 1997 Apr; 29(4):1031-8. PubMed ID: 9095095
[TBL] [Abstract][Full Text] [Related]
11. The direct renin inhibitor aliskiren localizes and persists in rat kidneys.
Feldman DL; Jin L; Xuan H; Persohn E; Zhou W; Schuetz H; Park JK; Muller DN; Luft FC
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1593-602. PubMed ID: 23926182
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
Chen A; Cauchon E; Chefson A; Dolman S; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Gallant M; Grimm E; Han Y; Houle R; Huang JQ; Hughes G; Jûteau H; Lacombe P; Lauzon S; Lévesque JF; Liu S; Macdonald D; Mackay B; McKay D; Percival MD; St-Jacques R; Toulmond S
Bioorg Med Chem Lett; 2011 Jul; 21(13):3976-81. PubMed ID: 21641209
[TBL] [Abstract][Full Text] [Related]
13. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren.
Barkoudah E; van Thiel BS; Fisher ND; Gregg RA; Danser AH; Moukarbel GV; Hollenberg NK
J Hypertens; 2016 May; 34(5):935-41. PubMed ID: 26882043
[TBL] [Abstract][Full Text] [Related]
14. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
McMahon EG; Yang PC; Babler MA; Bittner SE; Suleymanov OD; Cain-Janicki KJ; Bedell LJ; Hanson GJ; Cook CS
Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
[TBL] [Abstract][Full Text] [Related]
15. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes.
Ganten D; Wagner J; Zeh K; Bader M; Michel JB; Paul M; Zimmermann F; Ruf P; Hilgenfeldt U; Ganten U
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7806-10. PubMed ID: 1502199
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor.
Shibasaki M; Asano M; Fukunaga Y; Usui T; Ichihara M; Murakami Y; Nakano K; Fujikura T
Am J Hypertens; 1991 Dec; 4(12 Pt 1):932-8. PubMed ID: 1815649
[TBL] [Abstract][Full Text] [Related]
17. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
[TBL] [Abstract][Full Text] [Related]
18. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
Lambers Heerspink HJ; Perkovic V; de Zeeuw D
J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
[TBL] [Abstract][Full Text] [Related]
19. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
Miyazaki M; Etoh Y; Iizuka K; Toda N
J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609
[TBL] [Abstract][Full Text] [Related]
20. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
